#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Type IIa hyperlipidaemia Glycogen storage disease type I Ocular lymphoma Hidradenitis Biliary cancer metastatic Metachromatic leukodystrophy Pleural mesothelioma Germ cell cancer Gaucher's disease type I Systemic candida Marfan's syndrome Shprintzen-Goldberg syndrome Chorioretinitis Congenital absence of bile ducts Spinal muscular atrophy More trials…

    Learn about Rare Diseases

    Prader-Willi syndrome – Basic Information Hereditary ataxia – Life with Disease Paroxysmal nocturnal haemoglobinuria – Trials in Disease Langerhans cell sarcoma – Basic Information Pleomorphic leiomyosarcoma – Treatment Osteosarcoma recurrent – Basic Information Fabry’s disease – Trials in Disease MELAS syndrome – Basic Information Wiskott-Aldrich syndrome – Diagnostics Adrenocortical carcinoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Paroxetine Hydrochloride Gefurulimab Tofacitinib Citrate Elvn-002-1 Tranexamic Acid L-ARGININE Odm-212 Masitinib Gozetotide Alf-18 Cobamamide Mps-106 Corticosteroids, Plain M1P Dipotassium Salt Aluminium Macitentan GSKVX000000034794 Pyridoxine Hydrochloride Cefoxitin Sodium Pirtobrutinib Apitegromab More therapies…

    Learn about Your Condition

    Stomatitis Oral neoplasm Neoplasm malignant Venous thrombosis limb Yellow fever Arrhythmia Breast angiosarcoma metastatic Procedural headache Allergic respiratory disease Open angle glaucoma Nasopharyngeal cancer Pustular psoriasis Familial hypertriglyceridaemia Atopic keratoconjunctivitis Obsessive-compulsive disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Metastases to liver

  • Study on Preoperative Immunotherapy with Atezolizumab and Tiragolumab for Patients with Colorectal Liver Metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Metastases to liver
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Germany

  • Study on the Effects of Atezolizumab, Bevacizumab, Oxaliplatin, and Capecitabine in Patients with Colorectal Cancer and Liver Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Metastases to liver
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Capecitabine
    France

  • Study on Melphalan, Ipilimumab, and Nivolumab for Patients with Uveal Melanoma Liver Metastases

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    Norway Sweden

  • Study on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Metastases to liver
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Floxuridine
    • Heparin
    • Bevacizumab
    The Netherlands

  • Study on Treatment for Colorectal Liver Metastases Using Heparin, Dexamethasone, and Floxuridine for Patients with Heavy Tumor Burden

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to liver
    Investigated Drugs:
    • Floxuridine
    • Heparin
    • Dexamethasone Sodium Phosphate
    Norway

  • Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Metastases to liver
    Investigated Drugs:
    • Oxaliplatin
    Belgium France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!